Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SULBACTAM Cause Hepatic lesion? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hepatic lesion have been filed in association with SULBACTAM. This represents 6.9% of all adverse event reports for SULBACTAM.

9
Reports of Hepatic lesion with SULBACTAM
6.9%
of all SULBACTAM reports
9
Deaths
0
Hospitalizations

How Dangerous Is Hepatic lesion From SULBACTAM?

Of the 9 reports, 9 (100.0%) resulted in death.

Is Hepatic lesion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SULBACTAM. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does SULBACTAM Cause?

Drug ineffective (25) Foetal exposure during pregnancy (14) Abdominal pain (11) Cardiac arrest (11) Tachycardia (11) Nausea (10) Stevens-johnson syndrome (10) Abdominal distension (9) Anuria (9) Candida infection (9)

What Other Drugs Cause Hepatic lesion?

OCTREOTIDE (296) EVEROLIMUS (171) RIBOCICLIB (144) LETROZOLE (139) CAPECITABINE (124) ADALIMUMAB (123) METHOTREXATE (108) FULVESTRANT (107) PALBOCICLIB (104) CYCLOPHOSPHAMIDE (101)

Which SULBACTAM Alternatives Have Lower Hepatic lesion Risk?

SULBACTAM vs SULFACETAMIDE SULBACTAM vs SULFADIAZINE SULBACTAM vs SULFADIAZINE\TRIMETHOPRIM SULBACTAM vs SULFAMETHOXAZOLE SULBACTAM vs SULFAMETHOXAZOLE\TRIMETHOPRIM

Related Pages

SULBACTAM Full Profile All Hepatic lesion Reports All Drugs Causing Hepatic lesion SULBACTAM Demographics